Abstract: The present disclosure is directed to a method for selecting a patient with cancer for treatment with a compound of formula (I) by determining if the patient's cancer cells are MYC-positive and when the MYC promoter sequence in those cancer cells contains a nucleic acid sequence capable of forming a MYC G-quadruplex (MYC G4) (i.e. are MYC G4-positive) and treating the patient with a compound of formula (I).

Abstract: Techniques are provided for use in establishing and maintaining a contacting/communication service and/or network that does not necessarily require the use of dedicated server devices. For example, improved methods and apparatuses are provided that can be used to provide peer-to-peer (P2P) or other like forms of communication in such a manner that users can remain aware of others' online/offline statuses, search for other users, conduct audio/video talk and chat with others, exchange information, and/or communicate in other ways with one another.